|
The United Nations 57th Session of the Commission on the Status of Women (CSW)
|
Other
|
ACF, CDC
|
NIDA
|
The HHS Office of Global Affairs–International Health Action for a Healthier US is the lead office for HHS efforts. This office invited representatives from several HHS agencies to prepare for representing HHS at the Commission on the Status of Women (CSW) meeting in March 2013 in NY.
|
|
The United States Renal Data System (USRDS)
|
Resource Development
|
CMS, HRSA
|
NIDDK
|
The United States Renal Data System (USRDS) is a national data system that collects, analyzes, and distributes information about chronic kidney disease and end-stage renal disease (ESRD) in the United States. The missions of the USRDS are: (1) To characterize the total renal patient population and describe the distribution of patients by socio-demographic variables across treatment modalities; (2) To report on the incidence, prevalence, mortality rates, and trends over time of renal disease by primary diagnosis, treatment modality and other variables; (3) To develop and analyze data on the effect of various modalities of treatment by disease and patient group categories; (4) To identify problems and opportunities for more focused special studies of renal research issues; (5) To conduct cost effectiveness studies and other economic studies of ESRD; and (6) To make the data available to investigators, and by supporting investigator-initiated projects, to conduct biomedical and economic analyses of ESRD patients.
|
|
Therapeutics for Rare and Neglected Diseases (TRND)/FDA Working Group
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NCATS, CC, NICHD, NINDS
|
A group of NIH''s Therapeutics for Rare and Neglected Diseases (TRND) staff and FDA staff from the Center for Drug Evaluation and Research (CDER) meet on a semi-monthly basis to discuss projects for the TRND program. The purpose of this working group is to discuss the scientific progress on each project toward the eventual goal of an Investigational New Drug Application for each project. Results of experiments are discussed, and TRND staff takes the feedback of FDA/CDER staff into consideration when developing future project plans.
|
|
Think Tank on the Identifiability of Biospecimens and “-Omic” Data
|
Meeting/ Workshop
|
FDA, OS
|
NCI, NHGRI
|
Concerns regarding the potential identifiability of individuals from genomic or other "-omic" data, and from donated biospecimens coupled with publicly accessible information, have given rise to privacy policies and data security requirements which could limit the pace of progress in cancer research. The NCI Think Tank on the Identifiability of Biospecimens and "-Omic" Data was a 2-day workshop that gathered experts from various disciplines: researchers, ethicists, privacy law experts, patient advocates, and industry representatives, to review the state of the science and to explore the ramifications of suggested policy alternatives.
|
|
Third Pan-American Dengue Research Network Meeting
|
Meeting/ Workshop
|
CDC, FDA
|
NIAID
|
The September 2012 meeting provided a forum in which attendees exchanged information on basic and applied dengue research, identified research gaps and priorities, and ways to promote and stimulate research collaborations in the Americas.
|
|
Tobacco and Nicotine Research Interest Group (TANRIG)
|
Other
|
CDC, FDA, SAMHSA
|
NIDA, NCI, NHGRI, NHLBI, NIAAA, NIAID, NICHD, NIEHS, NIMH, NINR, OD/DPCPSI/OBSSR
|
Tobacco and Nicotine Research Interest Group (TANRIG) was formed in January 2003 with the goal of increasing collaboration, coordination, and communication of tobacco- and nicotine-related research among NIH institutes and centers, as well as with other relevant HHS agencies.
|
|
Tobacco Policy Modeling Workshop
|
Meeting/ Workshop
|
FDA
|
OD/DPCPSI/OBSSR, NCI, NIDA
|
The purpose of this Office of Behavioral and Social Sciences Research-led (OBSSR) meeting is to bring together systems science experts with tobacco control experts and government officials in order to: 1) assist in forming cross-disciplinary collaborations, 2) allow funding agencies to identify their programmatic priorities suited to exploration with modeling and simulation methods, and 3) develop recommendations for addressing challenges and capitalizing on opportunities in tobacco control using modeling and simulation methods.
|
|
Tobacco Product Interagency Agreement
|
Other
|
FDA
|
NCI
|
The FDA Center for Tobacco Products (CTP) and the NCI Office of Communications and Education are collaborating on an Interagency Agreement in which CTP will provide funds to NCI to provide planning, formative research, target messaging, creative content, outreach strategies, and communications support for a campaign to prevent underage tobacco use as it relates to FDA’s authorities under the Tobacco Control Act. Primary focus areas include multi-ethnic journalist training and outreach; development of a partnership strategy, digital strategy, social marketing tools; digital gaming best practices, and formation of a CTP communications workgroup comprised of subject matter experts.
|
|
Tobacco Regulatory Science Program (TRSP)
|
Research Initiative
|
FDA
|
OD/DPCPSI/ODP, NCI, OD/OER
|
Located in the NIH Office of Disease Prevention, the Tobacco Regulatory Science Program (TRSP) coordinates the trans-NIH collaborative effort with the Food and Drug Administration’s (FDA) Center for Tobacco Products (CTP) to conduct research to support its regulatory activities over tobacco products. Within the framework of the Tobacco Control Act, the NIH and FDA formed an interagency partnership to foster tobacco regulatory research. The NIH has the infrastructure for the solicitation, review, and management of research. The FDA has expertise in tobacco regulatory science and the authority and resources to support research responsive to FDA’s regulatory authority. Support from FDA was used to fund grants and to provide administrative support and oversight to manage Funding Opportunity Announcements (FOA), application review, policy implementation and oversight, and communicating and reporting to a variety of sources.
|
|
Tobacco Training Workgroup Subgroup of the NIH-FDA Tobacco Regulatory Science Workgroup
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
OD/DPCPSI/OBSSR, NCI, NICHD, NIDA, NIDCD, NIDCR, NIEHS, NIGMS, NIMH, NINDS, NINR, NLM
|
The Tobacco Training Workgroup Subgroup is focused on development of research training initiatives that fall within the scope of FDA''s Center for Tobacco Products and are administered by NIH.
|